Abstract
Introduction
IL-12, which was originally identified as a stimulator of NK icity, serum IFN-γ elevation and anti-metastatic activities in RAG-2 -/-mice, which lack conventional T cells and NKT cells, cell activity and a maturation factor for cytotoxic T lymphoand in CD1 -/-mice that only lack NKT cells. Our present cytes, plays an important role in the protection against results indicate that the relative contribution of NKT and NK microbial infections and the elimination of tumors (1, 2) . IL-12 cells varies depending on the dose of IL-12 administered and augments the cytotoxic activity of T cells, NK cells and that NKT cells are more sensitive to low-doses of IL-12 in vivo. NKT cells against a variety of target cells, and induces the production of IFN-γ by these cells (1) (2) (3) (4) (5) . In turn, IFN-γ activates macrophages to eliminate microbial agents and tumors, and Methods exerts additional anti-tumor activities by inhibiting angiogenMice esis (1, 2, 6) . It remains controversial, however, which lymphocyte population is most critically important in mediating the Male C57BL/6 (B6) mice, 6 weeks of age, were purchased anti-tumor activities of IL-12. Several studies suggested that from Clea Japan (Tokyo, Japan). B6 RAG-2 -/-mice were bred NKT cells were the major effector cells for IL- 12-induced in the Central Institute for Experimental Animals (Kawasaki, inhibition of experimental tumor metastasis (5, 7, 8) . On the Japan). CD1-deficient mice generated by targeted disruption other hand, we also observed that NK cells were sufficient of the CD1d gene have been described (10) . Homozygous for rejection of tumors by IL-12 (9) . To elucidate the relative (-/-) or control (ϩ/ϩ) (B6ϫ129/Sv)F 3 male mice were used contribution of NKT cells and NK cells to IL-12-induced at 8 weeks of age. All mice were maintained under specific pathogen-free conditions. immune responses, we analyzed the IL-12-induced cytotox-
IL-12
be 
Experimental lung metastasis model
Serum IFN-γ elevation was also partially impaired in RAG-2 -/-B16-BL6 melanoma cells (10 5 ), which were MHC class I -as mice when a low dose (500 U) of IL-12 was administered but estimated by flow cytometry, were injected through the tail not when a high dose (2000 U) was administered (Fig. 1C) . vein. Mice were sacrificed 14 days later and metastatic black Moreover, administration of a low dose of IL-12 (total of 1000 nodules on the lung surface were counted macroscopically U) over a period of 3 days after tumor injection induced as previously described (5,7).
reduced anti-metastatic activities against B16 melanoma cells in RAG-2 -/-mice as compared with normal mice; while a high Mononuclear cell (MNC) preparation and adoptive transfer dose (total of 3000 U) induced comparable anti-metastatic Hepatic MNC and splenic MNC were prepared as previously activities in these mice (Fig. 1D) . These results indicated that described (5,7). NK cells and NKT cells were isolated from RAG-2 -/-mice, which have normal or perhaps increased naive B6 hepatic and splenic MNC by the panning method. were significantly reduced in CD1 -/-mice when a low dose CD3 -CD122 ϩ NK cells. The NK cell fraction contained Ͼ90% (Ͻ1000 U) of IL-12 was administered, whereas a high dose CD3 -CD122 ϩ NK cells and~5% CD3 ϩ CD122 ϩ NKT cells.
(2000 U) of IL-12 induced comparable cytotoxicity in CD1 -/-and CD1 ϩ/ϩ mice. Similar results were obtained with splenic Cytotoxic assay MNC (data not sown). IL-12-induced serum IFN-γ levels were Cytolytic activity was assessed against B16-BL6 (NK-resistalso reduced in CD1 -/-mice when a low dose of IL-12 was ant) and YAC-1(NK-susceptible) target cells by a standard administered (Fig. 2C) . Moreover, anti-metastatic activities 51 Cr-release assay as previously described (5,7). against the experimental lung metastasis of B16 were reduced in CD1 -/-mice when a low amount (Ͻ2000 U) of IL-12 was ELISA injected, while a high amount (3000 U) of IL-12 induced Serum IFN-γ levels were evaluated using a specific ELISA kit comparable anti-metastatic activities in CD1 -/-and CD1ϩ/ϩ for mouse IFN-γ (Amersham, Little Chalfont, UK). mice (Fig. 2D) Fig. 3 (A and anti-metastatic effect in RAG-2 -/-mice (9). RAG-2 -/-mice lack NKT cells that have been reported to play a critical role and B), the adoptive transfer of NKT cells significantly enhanced the IL-12-induced cytotoxicity of splenic and hepatic in IL-12-induced immune responses (5, 7, 8, 11) . To further investigate the responsiveness of RAG-2 -/-mice to IL-12, we MNC against B16 cells, while transfer of NK cells did not. IL-12-induced serum IFN-γ levels were more markedly increased administered various amounts of IL-12 to RAG-2 -/-mice, in which only NK cells can be IL-12-responsive effector cells by the adoptive transfer of NKT cells than NK cells (Fig. 3C) . Moreover, the adoptive transfer of NKT cells substantially aug-(9), or normal B6 mice, in which both NKT and NK cells can mented the anti-metastatic activities of a low-dose (900 U) of and CD4 -CD8 -T lymphocytes, expressing an invariant TCR α chain composed of V α 14 rearranged to J α 281 and a semi-IL-12, whereas adoptive transfer of NK cells did not (Fig. 3D) . These results indicated that the in vivo activities of IL-12 are invariant TCR β chain (V β 8.2, V β 7 and V β 2) (15) (16) (17) . Although NKT cells were suggested to favor the establishment of a T h 2-mediated by both NK cells and NKT cells, but that the latter are more important.
type immune response through their ability to quickly secrete IL-4 (18), it has been shown that these cells are not absolutely required for the induction of T h 2 immune responses (10, 13, 14) .
Discussion
On the other hand, it has been suggested that NKT cells represent the predominant lymphocyte population that responds to ILIn this study, we demonstrated that IL-12-induced cytotoxicity, serum IFN-γ elevation and anti-metastatic activities were 12 and that mediates the anti-metastatic effects of this cytokine (5, 7, 8, 11) . However, we recently noted that NK cells, by themimpaired in NKT cell-deficient CD1 -/-and RAG-2 -/-mice when a low dose of IL-12 was administered. Moreover, adoptive selves, were able to mediate IL-12-induced cytotoxicity, serum IFN-γ production and anti-metastatic activities in RAG-2 -/-mice transfer of NKT cells but not NK cells could significantly restore the IL-12 responsiveness of RAG-2 -/-mice. These results sugwhen a high-dose of IL-12 was administered (9), suggesting that NKT cells are not absolutely necessary for IL-12-induced gested that NKT cells, as compared with NK cells, are more preferentially responsive to limited amounts of IL-12 in vivo.
immune responses. In the present study we clearly demonstrated that NKT cells are more responsive to IL-12 than NK NKT cells constitute a unique subset among mature CD4 ϩ cells: NKT cell-deficient RAG-2 -/-and CD1 -/-mice were be a critical component of NKT cell activation when these cells respond to their specific ligand(s) in physiological situations. impaired in low-dose but not high-dose IL-12 responses. These findings are consistent with our previous observation that NKT It should be noted that we investigated here anti-metastatic activities in an experimental model for tumor metastasis as a cells expressed higher levels of IL-12 receptors than NK cells (11) . Therefore, when a suboptimal dose of IL-12 is adminisbiological function of IL-12. In this model, NKT cells and/or NK cells are fully responsible for IL-12-induced anti-metastatic tered to NKT cell-deficient mice such as the RAG-2 -/-and CD1 -/-mice studied here, or the J α 281 -/-mice (8), profound activities, since depletion of NK1 ϩ cells in normal mice completely abolished these activities (22) . In contrast, in models of defects in tumor cell rejection may be observed.
Recently 
